We further tested the efficacy of indisulam in a syngeneic C-MYC neuroblastoma model, in which tumors derived from Dbh-iCre/CAG-C-MYC mice were engrafted in immune-competent mice of the same genetic background. Here, MYC is linked to neuroblastoma.